Dorchester Wealth Management CO Novo Nordisk A S Transaction History

Dorchester Wealth Management CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 13, 2023	SELL	$155.98 - $172.65 $38,995 - $43,162	-250 Reduced 7.08%	3,280 $530,000
Q1 2023 Apr 26, 2023	BUY	$132.34 - $159.14 $74,110 - $89,118	560 Added 18.86%	3,530 $561,000
Q4 2022 Jan 31, 2023	SELL	$102.55 - $135.33 $188,692 - $249,007	-1,840 Reduced 38.25%	2,970 $401,000
Q3 2022 Oct 24, 2022	SELL	$95.28 - $116.93 $47,640 - $58,465	-500 Reduced 9.42%	4,810 $479,000
Q2 2022 Aug 04, 2022	BUY	$103.24 - $121.81 $548,204 - $646,811	5,310 New	5,310 $592,000

1,955

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $246B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Dorchester Wealth Management CO, based on Form 13F filings with the SEC.

Stay updated on Dorchester Wealth Management CO with notifications on news.